Stay updated on Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical trial record is replaced by a 403 Forbidden message, so its study details are no longer displayed.
    Difference
    17%
    Check dated 2026-10-13T13:27:15.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a phase 2 study of nivolumab plus ipilimumab as neoadjuvant therapy for hepatocellular carcinoma. It includes the study’s design, eligibility requirements, locations, outcomes, and record dates.
    Difference
    48%
    Check dated 2026-10-06T13:55:20.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the full study record with an error page. This blocks access to the trial's content and navigational context, signaling an outage or restricted access.
    Difference
    17%
    Check dated 2026-09-22T21:49:52.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.7.0, replacing the previous Revision: v3.6.6, indicating a page version update. This is a maintenance update and does not change trial content or details.
    Difference
    0.1%
    Check dated 2026-09-15T21:39:29.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing v3.6.5, indicating a minor update to the study record presentation. No substantive study information appears to be changed.
    Difference
    0.1%
    Check dated 2026-09-01T19:34:18.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, signaling a new build of the page. This update represents a software/version change rather than a modification to the study details or results.
    Difference
    0.1%
    Check dated 2026-08-11T08:17:26.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.